Product Description
GS-0174 is a anti-c KIT drug candidate for Gilead Sciences used for transplant conditioning regimens. (Sourced from: https://www.gilead.com/science-and-medicine/pipeline)
Mechanisms of Action: C-KIT Antagonist
Novel Mechanism: No
Modality: Antibody
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|